Ceron, C., Castro, M., Rizzi, E., Montenegro, M., Fontana, V., Salgado, M., . . . Tanus-Santos, J. (2010). Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. Blackwell Publishing Ltd.

Ceron, CS, MM Castro, E. Rizzi, MF Montenegro, V. Fontana, MCO Salgado, RF Gerlach, and JE Tanus-Santos. Spironolactone and Hydrochlorothiazide Exert Antioxidant Effects and Reduce Vascular Matrix Metalloproteinase-2 Activity and Expression in a Model of Renovascular Hypertension. Blackwell Publishing Ltd, 2010.

Ceron, CS, et al. Spironolactone and Hydrochlorothiazide Exert Antioxidant Effects and Reduce Vascular Matrix Metalloproteinase-2 Activity and Expression in a Model of Renovascular Hypertension. Blackwell Publishing Ltd, 2010.